SPECIAL COURSE: Update on Brain Tumors: Prognostic Markers and Controversies in Diagnosis
Satellite Meeting on April 27, 2007 - Special Registration Required
(Member - $150; Nonmember - $200; Trainee - $75)
Register Online
Registration Form (PDF)
Organizer:  Barbara Crain (Johns Hopkins Univ. Sch. of Med.)
Chair: Gregory Fuller (Univ. of Texas MD Anderson Cancer Ctr.)
Sponsored by the American Association of Neuropathologists
Friday, April 27, 2007
8:00AM - 5:15PM
 

8:00 AM	INTRODUCTION and WELCOME. B.J. Crain, Johns Hopkins Univ. Sch. of Med. & G.N. Fuller, Univ. of Texas MD Anderson Cancer Ctr.
	NEW MARKERS FOR DIAGNOSIS OF BRAIN TUMORS
8:10 AM	Prognostic markers: molecular testing of GBM. P.S. Mischel, UCLA
9:00 AM	Prognostic markers: molecular testing of diffuse gliomas. D.N. Louis, Massachusetts Gen. Hosp.
9:50 AM	BREAK
10:20 AM	Prognostic markers: molecular testing and histologic grading of malignant posterior fossa brain tumors. D.W. Ellison, Newcastle Gen. Hosp.
11:10 AM	Emerging diagnostic markers: phospho-histone H3, MPM2, and the clinical utility of mitotic figure immunostains. K.D. Aldape, Univ. of Texas MD Anderson Cancer Ctr.
12:00 PM	LUNCH
	CONTROVERSIES IN DIAGNOSIS OF BRAIN TUMORS
1:15 PM	Controversies in surgical neuropathology: Glioneuronal tumors:  How many types are there?  How do you diagnose them? M.K. Rosenblum, Memorial Sloan-Kettering Cancer Ctr.
2:05 PM	Controversies in surgical neuropathology: what is a mixed glioma? G.N. Fuller, Univ. of Texas MD Anderson Cancer Ctr.
2:55 PM	BREAK
3:20 PM	Controversies surrounding brain tumor stem cells. C.G. Eberhart, Johns Hopkins Univ. Sch. of Med.
4:10 PM	New and interesting entities. P.C. Burger, Johns Hopkins Med. Inst.
5:00 PM	Closing comments. G.N. Fuller, Univ. of Texas MD Anderson Cancer Ctr.